Drug repurposing for cancer therapy
Y Xia, M Sun, H Huang, WL Jin - Signal Transduction and Targeted …, 2024 - nature.com
Cancer, a complex and multifactorial disease, presents a significant challenge to global
health. Despite significant advances in surgical, radiotherapeutic and immunological …
health. Despite significant advances in surgical, radiotherapeutic and immunological …
[HTML][HTML] Cardiovascular Risk Factors Predicting Cardiovascular and Cancer Deaths in a Middle-Aged Population Followed-Up for 61 Years until Extinction
A Menotti, PE Puddu, P Piras - Journal of Cardiovascular Development …, 2024 - mdpi.com
Background and Aim. To study the relationships of cardiovascular risk factors with cancer
and cardiovascular mortality in a cohort of middle-aged men followed-up for 61 years …
and cardiovascular mortality in a cohort of middle-aged men followed-up for 61 years …
Impact of Antihypertensive, Lipid-Lowering, and Antiplatelet Agents on Development of Hepatocellular Carcinoma in Patients with Fatty Liver Disease and Diabetes
HJ Cho, E Lee, SS Kim, JY Cheong - 2024 - researchsquare.com
We evaluated the effects of antihypertensives, lipid-lowering agents, and antiplatelet
medications on hepatocellular carcinoma (HCC) risk in patients with fatty liver disease (FLD) …
medications on hepatocellular carcinoma (HCC) risk in patients with fatty liver disease (FLD) …